Anakinra as first‐line disease‐modifying therapy in systemic juvenile idiopathic arthritis: report of forty‐six patients from an international multicenter series

…, E Janssen, AI Shulman, MB Son… - Arthritis & …, 2011 - Wiley Online Library
Objective To examine the safety and efficacy of the interleukin‐1 (IL‐1) receptor antagonist
anakinra as first‐line therapy for systemic juvenile idiopathic arthritis (JIA). Methods Patients …

Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study

MB Son, K Gauvreau, JC Burns, E Corinaldesi… - The Journal of …, 2011 - Elsevier
OBJECTIVE: To test the hypothesis that first re-treatment with infliximab, compared with
intravenous immunoglobulin (IVIG), might improve outcomes in IVIG-resistant Kawasaki disease. …

Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C)

…, M Lo, S Kahn, LA Henderson, PY Lee, MB Son… - Journal of Allergy and …, 2021 - Elsevier
Background Multisystem inflammatory syndrome in children (MIS-C) is a pediatric complication
of severe acute respiratory syndrome coronavirus 2 infection that is characterized by …

[HTML][HTML] Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases

…, A Shulman, V Sivaraman, MB Son… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Undifferentiated systemic autoinflammatory diseases (USAIDs) present
diagnostic and therapeutic challenges. Chronic interferon (IFN) signaling and cytokine …

Comparing presenting clinical features in 48 children with microscopic polyangiitis to 183 children who have granulomatosis with polyangiitis (Wegener's): an …

…, R Fuhlbrigge, M Hazen, MB Son… - Arthritis & …, 2016 - Wiley Online Library
Objective To uniquely classify children with microscopic polyangiitis (MPA), to describe their
demographic characteristics, presenting clinical features, and initial treatments in …

2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of Kawasaki disease

…, LF Imundo, SK Lapidus, S Kim, MB Son… - Arthritis care & …, 2022 - Wiley Online Library
Objective To provide evidence‐based recommendations and expert guidance for the
management of Kawasaki disease (KD), focusing on clinical scenarios more commonly addressed …

Socioeconomic and racial and/or ethnic disparities in multisystem inflammatory syndrome

…, M Day-Lewis, E Bucholz, R Kobayashi, MB Son… - …, 2021 - publications.aap.org
OBJECTIVES: To characterize the socioeconomic and racial and/or ethnic disparities impacting
the diagnosis and outcomes of multisystem inflammatory syndrome in children (MIS-C). …

COVID-19 in Pediatrics

SM Case, MB Son - Rheumatic Disease Clinics, 2021 - rheumatic.theclinics.com
In 2019, a novel coronavirus emerged called severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19). Initially identified in …

Treatment intensification in patients with Kawasaki disease and coronary aneurysm at diagnosis

…, K Gauvreau, SD de Ferranti, AL Baker, MB Son… - …, 2019 - publications.aap.org
… , Tremoulet, and Fournier were responsible for acquisition and interpretation of the data and
critically reviewed the manuscript for important intellectual content; Drs deFerranti, Son, and …

Interleukin-6 blockade with tocilizumab in anakinra-refractory febrile infection-related epilepsy syndrome (FIRES)

…, S Case, AJ Sansevere, MB Son… - Child Neurology …, 2020 - journals.sagepub.com
Febrile infection-related epilepsy syndrome (FIRES) is characterized by new onset refractory
status epilepticus in a previously healthy child that is associated with poor cognitive …